Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
202-213
Author(s):
R. Pignatello, D. Paolino, V. Panto, V. Pistara, M. G. Calvagno, D. Russo, G. Puglisi and M. Fresta
Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
950-956
Author(s):
Steven M. Larson
Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
966-982
Author(s):
J. Harvey Turner
Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
758-776
Author(s):
P. Sapra Sharma, R. Sharma and T. Tyagi
Chemosensitization and Immunosensitization of Resistant Cancer Cells to Apoptosis and Inhibition of Metastasis by the Specific NF-κB Inhibitor DHMEQ
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
792-808
Author(s):
Alina Katsman, Kazuo Umezawa and Benjamin Bonavida
Anticancer Agents: VTA or VDA
Journal:
Current Bioactive Compounds
Volume:
5
Page:
79-97
Author(s):
Paul R. Sebahar, J. Adam Willardsen and Mark B. Anderson
Potential Novel Targets in Breast Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
148-153
Author(s):
Pranela Rameshwar
Tumor Initiating Cells
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
192-196
Author(s):
Nitu Bansal and Debabrata Banerjee
Novel Classes of Dimer Antitumour Drug Candidates
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
659-674
Author(s):
Larry M.C. Chow and Tak Hang Chan
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
32-71
Author(s):
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento